Off-Label Drugs: Medicare May Cover Unlisted Uses, But Expect to Back Them Up

Why This Topic Matters

Off-label prescribing can create reimbursement uncertainty and documentation risk. Understanding the general Medicare review framework helps practices prepare supporting records and reduce the chance of denied claims or patient billing disputes.

Article Sections

1. Overview of off-label prescribing and Medicare coverage

   Introduces the topic of off-label drug use and the general question of how Medicare may handle payment for these prescriptions. It frames the article around coverage review and medical necessity considerations.

2. How Medicare evaluates support for unlabeled drug use

   Describes the sources and review concepts Medicare may use when considering whether an off-label use is supported. The section also references the role of physician judgment in coverage review.

3. Practical considerations for documentation and billing

   Summarizes practice-level considerations that may affect claim handling, patient communication, and billing preparation when a drug is prescribed for an off-label purpose.